This review outlines the epidemiology and potential new risk factors for recurrent venous thrombosis to help balance the risks and benefits of anticoagulant treatment.
No takes yet. Share an insight, caveat, or question.
May inform anticoagulation decisions in recurrent venous thrombosis; leaves open prospective validation of new risk factors.
Ribeiro et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: